Applications Of Visual Evoked Potentials And Fourier-domain Optical Coherence Tomography In Parkinson's Disease: A Controlled Study. by Quagliato, Lucas Barasnevicius et al.
Original Article 
238 Arq Bras Oftalmol. 2014;77(4):238-42 http://dx.doi.org/10.5935/0004-2749.20140061
INTRODUCTION
Parkinson’s Disease (PD) is the second most common neurode-
generative disease, affecting 1-2 % of the world’s population above 
the age 65(1). The non-motor symptoms (olfactory, autonomic, and 
visual) of PD have been described. Ophthalmological symptoms 
include blurred vision due to dry eye, and diplopia from convergen-
ce insufficiency. Additionally, it has been reported that PD patients 
present abnormalities in pattern-shift visual evoked potentials (VEP), 
contrast sensitivity, and colour vision(3-5). The human retina contains 
dopaminergic amacrine and interplexiform cells, which play a regula-
tory role. Dopaminergic D1 and D2 receptors are essentials for the re-
ceptive field organization of the ganglion cells(6-9). Optical coherence 
tomography (OCT), a non-invasive optical interferometric method, 
generates cross-sectional retinal images in vivo. Earlier studies using 
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ABSTRACT 
Purpose: The goal of this cross-sectional observational study was to quantify 
the pattern-shift visual evoked potentials (VEP) and the thickness as well as the 
volume of retinal layers using optical coherence tomography (OCT) across a cohort 
of Parkinson’s disease (PD) patients and age-matched controls. 
Methods: Forty-three PD patients and 38 controls were enrolled. All participants 
underwent a detailed neurological and ophthalmologic evaluation. Idiopathic PD 
cases were included. Cases with glaucoma or increased intra-ocular pressure were 
excluded. Patients were assessed by VEP and high-resolution Fourier-domain OCT, 
which quantified the inner and outer thicknesses of the retinal layers. VEP laten-
cies and the thicknesses of the retinal layers were the main outcome measures. 
Results: The mean age, with standard deviation (SD), of the PD patients and controls 
were 63.1 (7.5) and 62.4 (7.2) years, respectively. The patients were predominantly 
in the initial Hoehn-Yahr (HY) disease stages (34.8% in stage 1 or 1.5, and 55.8 % in 
stage 2). The VEP latencies and the thicknesses as well as the volumes of the retinal 
inner and outer layers of the groups were similar. A negative correlation between 
the retinal thickness and the age was noted in both groups. The thickness of the 
retinal nerve fibre layer (RNFL) was 102.7 μm in PD patients vs. 104.2 μm in controls. 
Conclusions: The thicknesses of retinal layers, VEP, and RNFL of PD patients were 
similar to those of the controls. Despite the use of a representative cohort of PD 
patients and high-resolution OCT in this study, further studies are required to 
establish the validity of using OCT and VEP measurements as the anatomic and 
functional biomarkers for the evaluation of retinal and visual pathways in PD patients. 
Keywords: Evoked potentials, visual; Tomography, optical coherence/methods; 
Parkinson disease
RESUMO 
Objetivo: Este estudo observacional transversal controlado visou quantificar os 
potenciais evocados visuais com estímulo de padrões alternantes (PEV), a espessura 
e o volume das camadas retinianas com tomografia de coerência óptica (TCO) num 
grupo de pacientes com doença de Parkinson (DP). 
Métodos: Quarenta e três pacientes com DP e 38 controles. Procedimentos: pacientes 
e controles foram submetidos a exames neurológico e oftalmológico detalhados, 
sendo incluídos pacientes com DP idiopática e excluídos casos com glaucoma ou 
aumento da pressão intraocular. Todos os participantes foram estudados com PEV e 
TCO de Fourier, sendo quantificadas as latências de P100, a espessura e o volume das 
camadas retinianas interna e externa. 
Resultados: A média das idades e desvio-padrão dos pacientes com DP e controles 
foram respectivamente 63,1(7,5) e 62,4 (7,2) anos. Os pacientes com DP situaram-se 
predominantemente nos estágios iniciais de Hoehn-Yahr (34.8% no estágio 1 ou 1.5; 
55.8 % no estágio 2). Não foram observadas diferenças entre os dois grupos quanto às 
latências dos PEV, a espessura e o volume das camadas retinianas. Observamos uma 
correlação negativa entre a espessura das camadas retinianas e a idade em ambos 
os grupos. Não se observou diferença significativa quanto à espessura da camada 
retiniana das fibras do nervo óptico (CRFNO), que foi de 102,7 μm nos pacientes e 
104,2 μm nos controles. 
Conclusões: A espessura das camadas retinianas, os PEV e a espessura da CRFNO 
foi semelhante nos pacientes com DP e controles. Apesar desse grupo representativo 
de pacientes com DP e da alta resolução da TCO utilizada neste estudo, mais estudos 
são necessários para estabelecer o papel da TCO e dos PEV como biomarcadores 
anatômico e funcional na avaliação da retina e da via visual dos pacientes com DP. 
Descritores: Potenciais evocados visuais; Tomografia de coerência óptica/métodos; 
Doença de Parkison
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time-domain and spectral-domain OCT have found evidence for 
the retinal changes in PD patients. However, these findings have not 
been independently verified. Four separate studies have reported 
thinning of the inner retinal layer in PD patients(10-13). Two of these 
studies found a significant thinning of the peripapillary retinal nerve 
fibre layer (RNFL) only in the inferior and temporal retinas of some 
PD patients(10,13). An independent study found a reduction in the 
mean total thickness of the peripapillary RNFL and reduced macular 
volume in 17 PD patients(11). Further, there was an inverse correlation 
between the macular thickness and the motor handicap. The objecti-
ves of this study were to define VEP and Fourier-domain high-reso-
lution OCT images as functional and biological marker, respectively 
of PD. These tools allow the analysis of maculo-cortical pathway (via 
VEP) and enable retinal measurements (via OCT), and therefore, could 
address the retinal contribution to the visual dysfunction in PD. 
METHODS
PaTIeNTs aND sTUDy POPUlaTION
This cross-sectional observational study recruited 43 idiopathic 
PD patients and 38 age-matched controls from a specialised PD 
clinic. A neurologist (E.M.A.B.Q), who also performed the VEP measu-
rements, made the diagnosis based on the UK Brain Bank criteria(14) 
and applied the United Parkinson Disease Scale (UPDRS). Patients 
were under dopaminergic medications at the time of the study. 
The Hoehn-Yahr (HY) stage was established in an off stage, without 
the effects of medication. All patients were between the HY stages 
1 and 3 (mean 1.78). Exclusion criteria were the following: systemic 
co-morbidities such as neoplasia, diabetes, severe arterial hyper-
tension, glaucoma or intraocular pressure greater than 20 mmHg, 
posterior-pole eye diseases such as macular degeneration or any 
optic neuropathy, or a best-corrected visual acuity worse than 20/30. 
The ophthalmologic evaluation and the OCT were performed at an 
on stage by one of three ophthalmologists involved in this study 
(L.B.Q., C.D., and E.B.A.) and comprised a visual acuity test (Snellen 
table), an Ishihara colors test, a biomicroscopy, and an intraocular 
pressure measurement using the Goldmann applanation tonometer. 
We examined 86 eyes of 43 PD patients and 76 eyes of 38 controls. All 
participants signed an informed consent form. The study was appro-
ved on 8/24/2010 by the ethical committee of the State University of 
Campinas (SP) and was conducted according to the Good Practice 
Guidelines (1977), the Helsinki Declaration (2000 version), and the 
Brazilian Clinical Study Guidelines. 
eqUIPmeNT aND measURes
Neurophysiologic analysis: a Nihon-Kohden 4-channel device 
registered VEP using a full-field checkerboard pattern (black and white), 
applying a 2-Hz stimuli and a controlled background luminance. 
Responses to the stimuli with a visual angle of 30’ were considered for 
statistical analysis. Electrodes were placed on the scalp according to 
the 10/20 International System. The electrode was placed 5 cm above 
the inion and the reference electrode was placed over the midline 
frontal region (FpZ). Eyes were stimulated individually. The average 
responses from two trials of 150 stimuli for each eye were superimpo-
sed using a 1-Hz-100-Hz filter. Latencies and amplitudes of N75, P100, 
and N135 were measured. However, only the P100 latencies were 
considered for statistical analysis.
Morphological analysis: a Fourier-domain OCT (RTvue; Optovue, 
Cal, USA), with an approximate resolution of 5 μm, was used for exa -
mining the retinal morphology. The OCT examined an area corres-
ponding to the central and paracentral visual fields. The standard 
glaucoma protocol, consisting of optic nerve head map scans and 
macula map scans, was performed in both PD patients and controls. 
The protocol measured the mean inner (IRL), outer (ORL), and full 
retinal layer (FRL) thicknesses, the volume of the parafoveal (diame-
ter=3.00 mm) and perifoveal (diameter 5.00 mm) regions, and the 
RNFL average mean thickness over a diameter of 3.45 mm for both 
superior and inferior hemispheres. The IRL includes the nerve fibre 
layer, the ganglion cell layer, and the inner plexiform layer. The ORL 
includes the retinal layers starting from the inner nuclear layer up to 
and including the retinal pigment epithelium. The OCT instrument 
was equipped with an eye tracker that compensated for the eye 
movement. When motion or media artefacts were detected, the OCT 
measurements were repeated.
sTaTIsTICal aNalysIs
Statistical analysis was performed using the descriptive statistics 
and employed no parametric tests. The data have been presented 
as the mean values and standard deviation to enable comparisons 
with published results. The Chi-square and Fisher’s exact tests (for 
values less than 5) were used to compare the categorical variables. 
The Mann-Whitney and Kruskal-Wallis tests were used for comparing 
the numeric variables between two or three groups. The Spearman 
rank coefficient (r) was used to analyze the relationships between the 
numerical variables. Correlation was considered strong if r≥0.70, mo-
derate if 0.70>r>0.50, weak if 0.20<r<0.50, and no correlation if r≤0.20. 
The adopted significance level for the statistical tests was 5% (P<0.05). 
RESULTS
The age frequencies were similar in both groups-28 subjects 
between the ages of 50 and 59 years (13 controls and 15 PD), 37 
su bjects between the ages of 60 and 69 years (18 controls and 19 
PD), and 16 subjects between the ages of 70 and 79 years (7 controls 
and 9 PD) (Q-square=0.11, P=0.946). Thirteen PD patients (31.28%) 
and 8 control subjects (22.21%) included symptoms (P=0.365) such 
as visual tiredness (10 patients), dry eye (5), and blurred vision (5). 
Similarly, the symptoms presented by the control subjects include 
tiredness (2), dry eye (2), and blurred vision (5). Basic demographic 
data are shown in table 1.
CONTROl gROUP vs. PD gROUP: IshIhaRa COlOR TesT
The scores of PD patients and control subjects were normal 
(91.89% and 97.37%, respectively; P=0.358).
CONTROl gROUP vs. PD gROUP: vIsUal evOkeD POTeNTIals
The mean (SD) P100 cortical latencies obtained after stimulating 
the right eye of controls and PD patients were 106.35(6.99) ms and 
108.36(10.23) ms (P=0.365), respectively. The mean cortical latencies 
for the left eye were 108.15(6.97) and 109.13(8.87) ms (P=0.728), res-
pectively. The average of the P100 latencies of the right and left eyes 
were 107.25(6.57) ms and 108.75(9.27) ms, respectively in controls 
and PD patients (P=0.516). Thus, the cortical VEP responses (P100), 
with a visual angle of 30’, showed similar latencies in both patients 
and controls.
Table 1. Basic demographic data
Controls n=38 PD n=43 P value
Age (years) (SD) 62.4 (7.2) 63.1 (7.55) 0.656
Gender (% male) 46.15 62.79 0.131
Race (% white) 97.37 93.20 0.700
PD duration (years) (SD) 6.98 (4.13)
Normal Ishihara color test (%) 97.37 91.89
Hohen-Yahr stages 1 and 1.5 (%) 34.88 0.358
Hohen-Yahr stage 2 (%) 55.81
Hohen-Yahr stages 2.5 and 3 (%) 09.31
UPDRS total (mean) (SD) 17,63 (8.99)
UPDR= united Parkinson disease rating scale; Statistical tests= Chi-squared and Fisher’s 
exact test. 
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Within the control group, there was a positive correlation between 
the age, and the cortical VEP latencies of the right and left eyes 
(r=0.42543 and 0.43343, respectively; P=0.0108 and 0.0093, respec-
tively), and between the age and the average of the latencies of the 
right and left eye (r=0.41969, P=0.0121). In the PD group, there was 
no correlation between the age and the VEP latencies of the right and 
left eyes (r=0.05669 and 0.10101; P=0.7214 and 0.5245, respectively), 
and the average of the latencies of the right and left eyes (r=0.07507; 
P=0.6366). There was no correlation between the PD duration and 
the VEP latencies for the right eyes and left eyes (r=0.21453 and 
r=0.07592; P=0.1725 and 0.6328, respectively), as well as between 
the PD duration and the average of the VEP latencies of the right and 
left eyes (r=0.13992, P=0.3768). There was no correlation between the 
HY stage and the VEP latencies of the right and left eyes (r=0.06210 
and 0.03200, respectively; P=0.6960 and 0.8405, respectively), and 
between the HY stage and the average of the VEP latencies of the 
right and left eyes (r=0.04989, P=0.7537). There was no correlation 
between the UPDRS total scores and the VEP latencies for the right 
and left eye (r=0.1482 and 0.20985, respectively; P=0.3635 and 
0.1822, respectively), and between the UPDRS total scores and the 
average of the latencies of both eyes (r=0.21471, P=0.1721).
CONTROl gROUP vs. PD gROUP: OPTICal COheReNCe TOmOgRaPhy
The mean (SD) interocular RNFL thickness was similar in controls 
[104.17 (12.31) μm] and PD patients [102.68 (11.50) μm] (P=0.169). The 
inner, outer, and, the total layer thicknesses as well as the volumes of 
the parafoveal and perifoveal regions of both eyes of the PD patients 
were similar to those of controls. The OCT results are summarised in 
tables 2 and 3.
CORRelaTIONs IN PD gROUP
A negative correlation was found between the age of the PD 
patients and the retinal layer thickness as well as the volume. In-
creased age was associated with a thinner right eye inner perifoveal 
layer (Figure 1), lower right eye inner perifoveal layer volume 
(r=-0.41840, P=0.0080), and lower total right eye perifoveal layer thickness 
(r=-0.32039, P=0.0468). 
There was no correlation between the PD patients’ age and the 
inner and outer parafoveal thicknesses and volumes of the right eye, 
and between the age and the inner and outer parafoveal and perifo-
veal thicknesses and volumes of the left eye (r<-0.20)
A negative correlation was observed between the disease du-
ration and the retinal layer thickness and volume. Extended disease 
duration was associated with reduced left eye inner parafoveal layer 
thickness and volume (r=-0.35717, P=0.0256).
There was a negative correlation between the total UPDRS scores 
and the total parafoveal thickness (r=-0.33281, P=0.0383).
There was no correlation between the HY stage and the retinal 
layer thickness and volume in either eyes (r<0.1, P>0.05). The RNFL 
did not correlate with patients’ age, PD duration, or the HY stage 
(P>0.05). There was no correlation among the RNFL thickness, VEP 
latency, patients’ age, PD duration, or the HY stage (r<-0.20; P>0.05).
The mean RNFL thickness correlated positively to the inner 
perifoveal retinal layer thickness (r=0.60302, P<0.0001), its volume 
(r=0.59759, P<0.0001), and to the total parafoveal layer thickness 
Table 2. RNFL thickness and macular parafoveal layer thickness and 
volume analysis
Control PD P value
RNFL thickness (μm; SD) n=38 n=43
OD mean 105.85 (12.82) 103.09 (12.04) 0.098
OS mean 103.41 (11.58) 102.27 (12.19) 0.244
Mean macular thickness (μm; SD)
OD inner parafoveal layer 123.00 (10.98) 121.51 (11.03) 0.552
OS inner parafoveal layer 120.67 (16.16) 125.18 (09.88) 0.310
Mean inner interocular parafoveal 121.83 (11.40) 123.35 (09.42) 0.908
OD outer parafoveal layer 193.18 (45.16) 188.05 (12.27) 0.738
OS outer parafoveal layer 183.21 (16.07) 184.41 (07.56) 0.936
Mean outer interocular parafoveal 188.21 (25.16) 186.23 (08.45) 0.708
OD total parafoveal layer 309.03 (16.38) 309.33 (14.40) 0.897
OS total parafoveal layer 303.97 (30.62) 309.59 (14.40) 0.712
Mean macular volume (mm3)
OD inner parafoveal 0.77 (0.07) 0.76 (0.07) 0.566
OS inner parafoveal 0.76 (0.10) 0.79 (0.06) 0.310
Mean inner interocular 0.77 (0.77) 0.78 (0.06) 0.787
OD outer parafoveal 1.17 (0.06) 1.18 (0.08) 0.617
OS outer parafoveal 1.15 (0.10) 1.14 (0.11) 0.899
Mean outer interocular 1.16 (0.07) 1.16 (0.08) 0.583
P values are based on the Mann-Whitney test.
Table 3. Macular perifoveal layer thickness and volume analysis
Control PD P value
Mean macular thickness (μm; SD)
OD inner perifoveal layer 111.56 (08.17) 110.31 (07.28) 0.352
OS inner perifoveal layer 110.21 (09.78) 111.87 (07.17) 0.908
Mean inner interocular perifoveal 110.88 (08.08) 111.09 (06.82) 0.715
OD outer perifoveal layer 172.90 (09.92) 171.74 (08.10) 0.799
OS outer perifoveal layer 172.10 (09.61) 171.03 (07.91) 0.572
Mean outer interocular perifoveal 172.50 (08.99) 171.38 (07.15) 0.734
OD total perifoveal layer 284.67 (15.37) 282.00 (11.93) 0.352
OE total perifoveal layer 282.44 (17.97) 282.21 (12.80) 0.664
Mean macular volume (mm3)
OD inner perifoveal 1.40 (0.10) 1.39 (0.09) 0.261
OS inner perifoveal 1.39 (0.12) 1.40 (0.10) 0.976
Mean inner interocular perifoveal 139 (0.10) 1.39 (0.09) 0.621
OD outer perifoveal 2.17 (0.13) 2.16 (0.10) 0.810
OS outer perifoveal 2.14 (0.22) 2.09 (0.13) 0.240
Mean outer perifoveal 2.16 (0.15) 212 (0.13) 0.353
P values are based on the Mann-Whitney test.
Figure 1. Correlation between patients’ age and right eye inner perifoveal layer thickness.
RE= right eye; r=-0.42454, P=0.007.
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(r=0.46176, P=0.0031). The VEP latencies were not correlated to the 
inner perifoveal and parafoveal retinal layer thickness or volume 
(r<0.20, P>0.05). 
The mean interocular outer parafoveal retinal layer thicknesses (SD) 
were, 183.7 (8.40) μm in females and 188.21 (8.02) μm in males 
(P=0.036). The mean interocular outer parafoveal retinal layer volu-
mes (SD) were, 1.15 (0.05) mm3 in females vs. 1.17 (0.09) mm3 in males 
(P=0.040). The total parafoveal layer thicknesses (SD) were, 302.97 
(11.81) μm in females vs. 313.52 (13.48) μm in males (P=0.017). The 
VEP P100 latency was lower in female (104.88 ms) than in males 
(111.13 ms, P=0.002) PD patients. In controls, gender-specific diffe-
rences in VEP or retinal layer thicknesses were not observed.
There was no correlation among the presence of visual symptoms, 
the mean interocular retinal layer thicknesses and volumes (inner and 
outer, parafoveal and perifoveal), the RNFL thickness, and the mean 
P100 VEP latency (r<0.20, P>0.05). 
There was no correlation among the Ishihara scores, the mean 
interocular retinal layer thickness, its volume, the mean interocular 
RNFL thickness, and the mean interocular P100 VEP latency (r<0.20, 
P>0.05).
CORRelaTIONs wIThIN The CONTROl gROUP 
Older age was positively correlated with increased VEP latencies 
of the right eye (r=0.42543, P=0.0108) and the left eye (r=0.43343, 
P=0.0093), as well as with increased mean VEP latencies (r=0.41969, 
P=0.0121).
Older age negatively correlated with reduced right eye total perifo-
veal retinal layer thickness (r=-0.32861, P=0.0440), left eye inner perifo-
veal layer thickness (r=-0.38507 P=0.0170), and volume (r=-0.39097, 
P=0.0152). Older age correlated negatively with lower mean inner 
perifoveal thickness (r=-0.3483, P=0.0318) and volume (r=-0.33693, 
P=0.0386). 
The mean interocular retinal layer thicknesses and volumes (inner 
and outer, parafoveal and perifoveal), the mean interocular RNFL 
thickness, and the mean interocular P100 VEP latency of males and 
females were similar (P>0.05).
The RNFL thickness did not correlated with age (r=-0.17161, 
P=0.3029). There was a positive correlation between the RNFL thi-
ckness and the mean interocular parafoveal inner layer thickness 
(r=0.39658, P=0.0124) as well as between the RNFL thickness and 
volume (r=0.39332, P=0.0132). The RNFL thickness positively correla-
ted with the mean interocular inner perifoveal thickness (r=-0.61725, 
P<0.0001) and volume (r=0.63374, P<0.0001), the mean interocu-
lar outer perifoveal thickness (r=0.40547, P=0.0104) and volume 
(r=0.41664, P=0.0083), and with the mean interocular total perifoveal 
thickness (r=0.5466, P=0.0003).
There was no correlation between the RNFL thickness and the 
VEP latency (r=-0.23014, P=0.1835). 
The complaints regarding vison did not correlate with the mean 
interocular retinal layer thickness (inner and outer, parafoveal and 
perifoveal), mean interocular RNFL thickness, and mean interocular 
P100 VEP latency (r<0.20, P>0.05). 
DISCUSSION
The impact of PD increases with life expectancy. Difficulty in 
reading, tiredness of the eyes, diplopia, and blurring of vision are 
commonly experienced by PD patients(15). Impairments in vision can 
be due to dysfunctions ranging from that of the extrinsic ocular mus-
cles to that of the occipital visual cortex(16,17). Whereas some deficits 
likely originate from the central processing tertiary visual areas, other 
symptoms are related to the alterations in visual acuity and colour, 
motion, as well as contrast perception. These symptoms have rarely 
been associated with PD(16). However, one post-mortem study that 
employed liquid chromatography found reduced dopamine content 
in the retinas of PD patients(18). 
Because PD occurs predominately in population over the age 
of 50, it was hypothesised that there could be a higher incidence of 
vision-related complaints in these patients than in controls. However, 
our results show that visual impairments occurred both in patients 
(31.58%) and controls (22.22%). Thus, our cohort of PD patients did 
not emphasise visual complaints other than those secondary to their 
handicapping motor symptoms(19). Similar to that observed in control 
group, the most frequently encountered visual symptoms in PD pa-
tients were the visual tiredness and blurred vision.
The mean age of this cohort of 43 PD patients was 63.07 years 
(79.02% between 50 and 69 years), which was similar to that in the 
control group of 38 individuals (62.39 years). The mean PD duration 
and HY stage were 6.97 years and 1.78, respectively, which indicated 
instances of initial to intermediate stages of PD. The total UPDRS 
mean score (SD) was 17.63 (8.99), indicating a light to moderate se-
ve rity of PD symptoms.
The results of the Ishihara visual color test were normal for 91.89% 
of PD patients and 97.37% of controls. These results suggested that 
the Ishihara visual color test is not appropriate for assessing the co-
lour vision of PD patients. The Farnsworth-Munsell 100 colour test is 
considered as the best method for evaluating the color perception(20).
The VEP P100 latencies of the PD patients and age-matched 
controls were similar. We chose the 30´ angle check size because it 
is between the 60´ (1 degree, perimacular function test) and the 15´ 
(0.25 degree, foveal function test) check sizes. Because various studies 
used different VEP stimuli, a comparison of the results is not practi-
cal(6,21,22). The VEP latencies did not correlate with the age, PD duration, 
and the HY stage. However, the VEP latencies and age of subjects in 
the control group showed an expected positive correlation. Thus, the 
pattern-shift VEP is a relatively poor method for assessing the anterior 
visual pathway dysfunction because it is incapable of differentiating 
impaired macular function from impaired ganglion cell function. Ho-
wever, the pattern electroretinogram would be able to differentiate 
these processes and assess the status of the retinal ganglion cells(23).
The spectral-domain OCT data did not show any differences in 
the inner or outer parafoveal and perifoveal retinal layer thicknesses 
and volume between the PD patients and controls. The PD stage did 
not correlate with the retinal layer thickness. Our results contradict 
the results of an earlier spectral-domain OCT study, which found 
inner retinal macular layer thinning in 24 PD patients(12). Altintas et al., 
who used time-domain OCT in their study of 17 PD patients (11 con-
trols) found a thinning of the inner superior, outer inferior temporal, 
and nasal macular regions, as well as a lower mean macular volume 
and an inverse correlation between the foveal thickness and motor 
handicap(11). Albrecht et al. found a thicker inner nuclear layer in 40 
PD patients. Factors, such as the different methods used for measu-
ring the retinal layers and measuring only at their thickest sections, 
may have contributed to these differences(24). The relatively smaller 
sample size used in earlier studies may also have contributed to the 
differences in the results of OCT(12,16).
Our results are similar to that of Archibald et al., who found no 
differences between the macular thicknesses of 32 PD patients and 
19 controls(16). Schneider et al used a newly developed semiauto-
matic algorithm for spectral domain OCT. This algorithm enabled a 
retinal single-layer analysis and calculation of the average thickness 
of retinal layers in Parkinsonian syndromes. The authors calculated 
the average thickness of single retinal layers to foveal scans of 65 
PD patients, 16 progressive supranuclear palsy (PSP) patients, 12 pa-
tients with multiple system atrophy (MSA), and 41 matched controls. 
Compared with controls, a significant reduction in the thickness of 
retinal layers was found only in PSP and MSA patients. The single 
retinal layer measurement of the PD patients revealed no significant 
changes. Notably, the thickening of the outer nuclear layer in PSP and 
that of the outer plexiform layer in MSA was highly specific to these 
diseases and helped distinguish PSP from MSA with high sensitivity 
and specificity(25). 
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The thickness of the RNFL of the PD patients was similar to that 
of the control subjects. Previous reports of OCT studies described a 
thinner RNFL in PD patients(10,11,13). However, Archibald et al. who em-
ployed time-domain OCT found no such thinning of the RNFL in PD 
patients(16). The RNFL thickness did not correlate with patient’s age, 
PD disease duration, and HY stage. Similar to that found in the con-
trol group, a positive correlation between the retinal layer thickness, 
volume, and RNFL thickness was observed. However, further studies 
are needed to verify the validity of these results. 
The effect of aging on retinal layer thickness was seen in both PD 
and controls, suggesting that the retinal thinning was age-related 
and cannot be considered as a biomarker of this disease. The male 
PD patients showed higher retinal layer thickness and volume than 
the female patients. Such gender differences were not observed in 
control group. A predominance of the initial stages of the disease was 
seen in the PD group. The HY stage did not correlate with the retinal 
layer thickness and volume. There were no correlations between VEP 
latencies and the retinal layer thickness and volume. 
In PD patients, gender differences in the mean outer interocular 
parafoveal and total thickness and the mean outer interocular para-
foveal volume were observed. These values were lower in females. 
However, such gender differences were not observed in the control 
group.
In both PD patients and controls, there was no correlation between 
complaints regarding vision, mean interocular retinal layer and mean 
RNFL thicknesses, retinal layer volumes, and the mean VEP latencies.
During this study, we encountered technical problems such as 
tremor interferences in OCT and VEP analyses. Therefore, we excluded 
those patients who could not tolerate the examinations and registers 
that did not have technical requirements for the analysis. Despite the-
se technical difficulties, our study included a considerable number of 
subjects because our inclusion/exclusion criteria were rigorous and 
excluded ocular and systemic pathologies.
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